Xiamen Amoytop Biotech (688278.SH) plans to issue convertible bonds to raise no more than 1.533 billion yuan.

TeBao Biotechnology (688278.SH) announced that the company plans to issue convertible bonds to unspecified investors, raising a total amount of funds not exceeding 1.533 billion yuan (including issuance expenses). The net proceeds from the fundraising, after deducting the issuance expenses, will be used for: new drug research and development projects, construction projects of the Biotechnology Innovation Integration Center, and the expansion project of TeBao Biotechnology's innovative drug production line.